Table 2.

Pathway enrichment in the group of patients at low risk of hypoxia in The Cancer Genome Atlas database.

NAME	SIZE	ES	NES	NOM p-val	FDR q-val	FWER p-val
OXIDATIVE_PHOSPHORYLATION	200	-0.6354224	-1.8517317	0.02	0.09670171	0.108
MYC_TARGETS_V1	196	-0.55293024	-1.5802475	0.091976516	0.29567894	0.452
E2F_TARGETS	198	-0.5320485	-1.5347565	0.115830116	0.25026736	0.533
FATTY_ACID_METABOLISM	156	-0.37549332	-1.483107	0.078125	0.24727894	0.605
PEROXISOME	104	-0.34722096	-1.4177548	0.08267716	0.26794004	0.708
BILE_ACID_METABOLISM	112	-0.33064038	-1.4166067	0.052529182	0.22491534	0.711
XENOBIOTIC_METABOLISM	197	-0.23699556	-1.0814732	0.31225297	0.6670434	0.973
MYC_TARGETS_V2	58	-0.4065364	-1.0632117	0.4333996	0.6178284	0.977
G2M_CHECKPOINT	195	-0.33763614	-1.0606128	0.425	0.55348146	0.978
DNA_REPAIR	150	-0.28392524	-1.0543846	0.39078155	0.50790316	0.981
PROTEIN_SECRETION	96	-0.30276886	-1.0146313	0.45114344	0.5174334	0.986
REACTIVE_OXYGEN_SPECIES_PATHWAY	49	-0.27658382	-0.960691	0.49802372	0.5441408	0.99
SPERMATOGENESIS	133	-0.2188226	-0.8435639	0.7213439	0.67120385	0.999
UNFOLDED_PROTEIN_RESPONSE	110	-0.18729709	-0.7100693	0.8192771	0.8042398	1